> Back to EJC

2016 editions

  • December 2016
    Joao Incio on mechanisms to explain why obesity promotes cancer.
  • November 2016
    Mike Stratton on how mutational changes in a cancer genome can point to the cause of the cancer.
  • October 2016
    Ruth Muschel on a new target for treatments for colorectal cancer.
  • September 2016
    Freddie Hamdy on the effectiveness of treatments for prostate cancer.
  • August 2016
    Moshe Oren discusses the effects of the microenvironment on cancer cells.
  • July 2016
    Richard Gilbertson on the 'bad luck hypothesis' for the cause of cancer.
  • June 2016
    Key advances in clinical trials.
  • May 2016
    Mark Lemmon on the underlying biochemistry of cancer.
  • April 2016
    Roger Stupp on using alternating electric fields as treatment.
  • March 2016
    Charlotte Vrinten on public perception of deaths from cancer.
  • February 2016
    Guillermo Garcia-Manero on myelodysplastic syndromes (MDS).
  • December 2015/January 2016
    Nazneen Rahman on germline genetic screening in ovarian cancer.

> All 2015 Editions

> All 2014 Editions

> All 2013 Editions

> All 2012 Editions

> All 2011 Editions

EJC News Focus – April 2016

Loading EJC News Focus video

Alternating electric fields - new evidence of efficacy

Scepticism was the initial response when the use of alternating electric fields (tumour treating fields) was first put forward as therapy for glioblastoma. But, at the recent Oncology at the Limits meeting in London, Roger Stupp, of University Hospital, Zurich, presented encouraging findings from a trial with this intriguing treatment modality.

He told delegates that overall survival and progression-free survival were significantly prolonged in patients who had received electric field therapy in addition to standard treatment.

Jim McGuigan asked him whether these preliminary trial findings suggested a viable new treatment for these patients.


Reference: JAMA 2015;314(23)